www.sinovac.com
Open in
urlscan Pro
47.246.24.200
Public Scan
Submitted URL: http://sinovac.cn.com/
Effective URL: http://www.sinovac.com/en-us
Submission: On February 01 via manual from CA — Scanned from CA
Effective URL: http://www.sinovac.com/en-us
Submission: On February 01 via manual from CA — Scanned from CA
Form analysis 2 forms found in the DOM
GET http://www.sinovac.com/search/index.php?lang=en-us
<form method="get" class="page-search-form" role="search" action="http://www.sinovac.com/search/index.php?lang=en-us" m-id="search_global" m-type="nocontent">
<input type="hidden" name="lang" value="en-us">
<input type="hidden" name="stype" value="0">
<div class="input-search input-search-dark">
<button type="submit" class="input-search-btn"><i class="icon wb-search" aria-hidden="true"></i></button>
<input type="text" class="form-control input-lg" name="searchword" value="" placeholder="Enter search keywords!">
</div>
</form>GET http://www.sinovac.com/search/index.php?lang=en-us
<form method="get" class="page-search-form" role="search" action="http://www.sinovac.com/search/index.php?lang=en-us" m-id="search_global" m-type="nocontent">
<input type="hidden" name="lang" value="en-us">
<input type="hidden" name="stype" value="0">
<div class="input-search input-search-dark">
<button type="submit" class="input-search-btn"><i class="icon wb-search" aria-hidden="true"></i></button>
<input type="text" class="form-control input-lg" name="searchword" value="" placeholder="Enter search keywords!">
</div>
</form>Text Content
* Company
* SINOVAC at Glance
* Our History
* Social Responsibilities
* Innovation
* Platform
* Pipeline
* Scientific Achievements
* Partners
* — Research Institute
* — Universities
* — Medical Institutions
* — Companies
* Products
* Vaccines
* International Business
* Quality Management System
* Product Consultation
* Adverse Event Report
* News
* Press Releases
* Updates and Statements
* Media Asset Library
* Investors
* Corporate Governance
* Financial Reports
* SEC Filings
* Careers
* Our Talent
* 中文 EN
* Contact Us
*
* Company
* SINOVAC at Glance
* Our History
* Social Responsibilities
* News
* Press Releases
* Updates and Statements
* Media Asset Library
* — Logo
* — Vaccines
* Innovation
* Platform
* Pipeline
* Scientific Achievements
* Partners
* — Research Institute
* — Universities
* — Medical Institutions
* — Companies
* Products
* Vaccines
* International Business
* Quality Management System
* Product Consultation
* Adverse Event Report
* Investors
* Corporate Governance
* — Board of Directors
* — Management
* Financial Reports
* — YEAR 2022
* — YEAR 2021
* — YEAR 2020
* — YEAR 2019
* — YEAR 2018
* — YEAR 2017
* — YEAR 2016
* — YEAR 2015
* — YEAR 2014
* — YEAR 2013
* — YEAR 2012
* — YEAR 2011
* — YEAR 2010
* — YEAR 2009
* — YEAR 2008
* — YEAR 2007
* — YEAR 2006
* — YEAR 2005
* — YEAR 2004
* — YEAR 2003
* SEC Filings
* — YEAR 2023
* — YEAR 2022
* — YEAR 2021
* — YEAR 2020
* — YEAR 2019
* — YEAR 2018
* — YEAR 2017
* — YEAR 2016
* — YEAR 2015
* — YEAR 2014
* — YEAR 2013
* — YEAR 2012
* — YEAR 2011
* — YEAR 2010
* — YEAR 2009
* Careers
* Our Talent
* Contact Us
*
* 联系我们
*
当前地点：
EN
选择地点：
* 中文
* EN
*
*
*
* Home
* Company
* SINOVAC at Glance
* Our History
* Social Responsibilities
* News
* Press Releases
* Updates and Statements
* Media Asset Library
* Innovation
* Platform
* Pipeline
* Scientific Achievements
* Partners
* Products
* Vaccines
* International Business
* Quality Management System
* Product Consultation
* Adverse Event Report
* Investors
* Corporate Governance
* Financial Reports
* SEC Filings
* Careers
* Our Talent
* Contact Us
* 中文
* EN
SUPPLY VACCINES TO ELIMINATE HUMAN DISEASES
* 1
* 2
* 3
* 4
SINOVAC Biotech Ltd. ("SINOVAC") is a China-based leading biopharmaceutical
company that focuses on the research, development, production, and
commercialization of vaccines that protect against human infectious diseases.
More
NEWS & EVENTS
More
2024/01/11
SINOVAC ANNOUNCES APPROVAL OF CLINICAL TRIAL FOR REASSORTANT HEXAVALENT
ROTAVIRUS VACCINE
Beijing, China – January 11, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the
"Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in
China, announced that Reass
* SINOVAC AND BOGOTÁ PRESENT BOGOTÁBIO, COLOMBIA'S FIRST PUBLIC VACCINE
MANUFACTURING FACILITY
The company's launch ceremony was led by Sinovac's CEO and Chairman, Mr.
Weidong Yin, alongside Bogotá's Mayor, Claudia López. December 18, 2023,
Bogotá, Colombia – Sinovac Biotech Ltd. (
2023/12/20
* CHILEAN PRESIDENT BORIC MEETS WITH SINOVAC CHAIRMAN AND CEO WEIDONG YIN
On December 12, 2023, Chilean President Gabriel Boric met with a delegation
led by Mr. Yin Weidong, Chairman, President, and CEO of SINOVAC, at the
Presidential Palace La Moneda in Chile. Both sides h
2023/12/12
* SINOVAC RECEIVES VISITS FROM BOGOTÁ MAYOR AND COLOMBIAN AMBASSADOR TO CHINA
IN BEIJING
On December 5, 2023, Mayor of Bogotá Claudia López and Colombian Ambassador
to China Sergio Caffaratti, visited Sinovac Biotech Ltd. ("SINOVAC" or the
"Company") in Beijing to meet
2023/12/07
R&D AND INNOVATION
SINOVAC has undertaken nearly 60 national and regional science and technology
R&D projects; received two State Scientific and Technology Progress Awards
and three national-level institutional technology awards; and published more
than
140 SCI papers, many of which were published in top academic journals including
New England Journal of Medicine, The Lancet, Science and Nature, etc.
More
OUR VACCINES
SINOVAC approved products include: COVID-19 Vaccine (Vero Cell), Inactivated -
CoronaVac®, Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®,
Hepatitis A Vaccine (Human Diploid Cell) Inactivated - Healive®, Influenza
Vaccine (Split Virion), Inactivated - Anflu®, 23-valent Pneumococcal
Polysaccharide Vaccine, Varicella Vaccine(Live), Mumps Vaccine(Live), etc.
COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®
Validated by the World Health Organization's Emergency Use Listing ("EUL")
Procedure on June 2, 2021
Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®
Validated by the World Health Organization's Emergency Use Listing ("EUL")
Procedure on June 2, 2021
Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®
Launched in 2002.
Influenza Vaccine Product Family
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent. Influenza Vaccine
(Split Virion), Inactivated - Anflu®. Pandemic Influenza Vaccine (Inactivated,
Adjuvanted) - Panflu®. H1N1 Influenza A Vaccine (Split Virion), Inactivated -
Panflu.1®.
23-Valent Pneumococcal Polysaccharide Vaccine
Launched in 2020.
Varicella Vaccine, Live - PROVARIX
Launched in 2020.
Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains
Launched in 2021.
Mumps Vaccine, Live
Launched in 2012.
COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®
Validated by the World Health Organization's Emergency Use Listing ("EUL")
Procedure on June 2, 2021
Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®
Validated by the World Health Organization's Emergency Use Listing ("EUL")
Procedure on June 2, 2021
Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®
Launched in 2002.
Influenza Vaccine Product Family
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent. Influenza Vaccine
(Split Virion), Inactivated - Anflu®. Pandemic Influenza Vaccine (Inactivated,
Adjuvanted) - Panflu®. H1N1 Influenza A Vaccine (Split Virion), Inactivated -
Panflu.1®.
23-Valent Pneumococcal Polysaccharide Vaccine
Launched in 2020.
Varicella Vaccine, Live - PROVARIX
Launched in 2020.
Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains
Launched in 2021.
Mumps Vaccine, Live
Launched in 2012.
COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®
Validated by the World Health Organization's Emergency Use Listing ("EUL")
Procedure on June 2, 2021
Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®
Validated by the World Health Organization's Emergency Use Listing ("EUL")
Procedure on June 2, 2021
Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive®
Launched in 2002.
Influenza Vaccine Product Family
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent. Influenza Vaccine
(Split Virion), Inactivated - Anflu®. Pandemic Influenza Vaccine (Inactivated,
Adjuvanted) - Panflu®. H1N1 Influenza A Vaccine (Split Virion), Inactivated -
Panflu.1®.
23-Valent Pneumococcal Polysaccharide Vaccine
Launched in 2020.
Varicella Vaccine, Live - PROVARIX
Launched in 2020.
Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains
Launched in 2021.
Mumps Vaccine, Live
Launched in 2012.
* Follow Us
*
*
*
*
*
*
© SINOVAC All rights reserved